AU2003284479A1 - Novel heteroaryl derivative - Google Patents

Novel heteroaryl derivative

Info

Publication number
AU2003284479A1
AU2003284479A1 AU2003284479A AU2003284479A AU2003284479A1 AU 2003284479 A1 AU2003284479 A1 AU 2003284479A1 AU 2003284479 A AU2003284479 A AU 2003284479A AU 2003284479 A AU2003284479 A AU 2003284479A AU 2003284479 A1 AU2003284479 A1 AU 2003284479A1
Authority
AU
Australia
Prior art keywords
heteroaryl derivative
novel heteroaryl
novel
derivative
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003284479A
Inventor
Katsunori Maruta
Ryu Nagata
Kantaro Ushiroda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of AU2003284479A1 publication Critical patent/AU2003284479A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
AU2003284479A 2002-11-28 2003-11-27 Novel heteroaryl derivative Abandoned AU2003284479A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002346388 2002-11-28
JP2002-346388 2002-11-28
JP2003169216 2003-06-13
JP2003-169216 2003-06-13
PCT/JP2003/015197 WO2004048341A1 (en) 2002-11-28 2003-11-27 Novel heteroaryl derivative

Publications (1)

Publication Number Publication Date
AU2003284479A1 true AU2003284479A1 (en) 2004-06-18

Family

ID=32396302

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003284479A Abandoned AU2003284479A1 (en) 2002-11-28 2003-11-27 Novel heteroaryl derivative

Country Status (3)

Country Link
JP (1) JPWO2004048341A1 (en)
AU (1) AU2003284479A1 (en)
WO (1) WO2004048341A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06000539A (en) * 2003-07-15 2006-03-30 Dainippon Sumitomo Pharma Co Novel heteroaryl derivative.
US7781479B2 (en) 2005-01-14 2010-08-24 Dainippon Sumitomo Pharma Co., Ltd. Heteroaryl derivatives
ES2376668T3 (en) 2006-09-05 2012-03-15 Kyowa Hakko Kirin Co., Ltd. IMIDAZOL DERIVATIVE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145922A0 (en) * 1999-04-28 2002-07-25 Aventis Pharma Gmbh Di-aryl acid derivatives as ppar receptor ligands
DE60012213T2 (en) * 1999-11-10 2005-07-21 Takeda Chemical Industries, Ltd. FIVE-GLASS N-HETEROCYCLES HAVING HYPOGLYKEMIC AND HYPOLIPIDEMIC EFFECT
CA2416946A1 (en) * 2000-07-28 2003-01-22 Sumitomo Pharmaceuticals Co., Ltd. Pyrrole derivatives
JP4213960B2 (en) * 2001-04-19 2009-01-28 大日本住友製薬株式会社 Pyrrole derivatives
JP2003171275A (en) * 2001-12-11 2003-06-17 Sumitomo Pharmaceut Co Ltd Ppar delta agonist
JPWO2003063861A1 (en) * 2002-01-30 2005-05-26 住友製薬株式会社 Fibrosis inhibitor
JP2003292439A (en) * 2002-02-04 2003-10-15 Sumitomo Pharmaceut Co Ltd Ppar activation agent composed of new pyrrole derivative
JP2003238403A (en) * 2002-02-08 2003-08-27 Sumitomo Pharmaceut Co Ltd Liver glyconeogenesis inhibitor composed of new pyrrole derivative
AU2003220896A1 (en) * 2002-03-28 2003-11-10 Sumitomo Pharmaceuticals Co., Ltd. Novel heteroaryl compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Also Published As

Publication number Publication date
WO2004048341A1 (en) 2004-06-10
JPWO2004048341A1 (en) 2006-03-23

Similar Documents

Publication Publication Date Title
AU2003211362A1 (en) N-hydroxycarboxamide derivative
AU2003294376A1 (en) Heteroaryl compounds
AU2003216013A1 (en) Novel adamantane derivatives
EP1682493B8 (en) Amidoacetonitrile derivatives
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
AU2003279366A1 (en) Novel compounds
WO2003072535A8 (en) Substituted hydroxyethylamines
EP1606277B8 (en) Imidazol-4-yl-ethynyl-pyridine derivatives
AU2003238043A1 (en) Substituted imidazotriazines
AU2003245984A1 (en) Hetero-cyclicaly substituted imidazotriazines
AU2003276509A1 (en) Context linking scheme
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
AU2003231388A1 (en) Novel piperidine derivative
AU2003264753A1 (en) 1-sulphonyl piperidine derivatives
AU2003220896A1 (en) Novel heteroaryl compounds
AU2003294900A1 (en) Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides
AU2003303648A1 (en) Novel 5-hydroxyindole-3-carboxylate derivatives
EP1706373B8 (en) Amidoacetonitrile derivatives
AU2003278369A1 (en) 3-cyano-quinoline derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003281366A1 (en) 1-aralkyl-n-(3-quinolyl)-1-cyclohexanecarboxamide derivative
AU2003212366A1 (en) Substituted 4-aminocyclohexanols
AU2003252333A1 (en) Novel tetrahydroquinoline derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase